Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization

BACKGROUND: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). However, limited studies have investigated the safety and effectiveness of SABR in patients with advanced diseases that is unsuitable for transar...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Med Oncol
Egile Nagusiak: Lee, Hsin-Lun, Tsai, Jo-Ting, Chen, Chun-You, Lin, Ying-Chun, Ho, Chin-Beng, Ting, Lai-Lei, Kuo, Chia-Chun, Lai, I-Chun, Lin, Chun-Yu, Tang, Jui-Hsiang, Huang, Yu-Min, Kao, Wei-Yu, Cheng, Sheng-Wei, Shen, Chia-Ning, Chen, Shang-Wen, Chiou, Jeng-Fong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2019
Gaiak:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893933/
https://ncbi.nlm.nih.gov/pubmed/31839809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919889002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak